Evaluating a Digitally Delivered, Multi-Modal Intervention for Parents of Children with Type 1 Diabetes: A

Tricia S Tang1,2, Niloufar Sharif3, Crystal Ng4,5

  • 1Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.

PubMed

Insights

A digital peer support program for parents of children with type 1 diabetes (T1D) was feasible and acceptable. The Huddle4Parents intervention used videoconferencing and texting to connect caregivers, showing high engagement and satisfaction.

Area of Science:

  • Digital health interventions
  • Parental support systems
  • Type 1 diabetes (T1D) management

Background:

  • Parents of school-aged children with T1D face unique challenges.
  • Digital interventions offer accessible support options.
  • Peer support can be a valuable resource for caregivers.

Purpose of the Study:

  • To assess the feasibility and acceptability of a digital peer support intervention for parents of children with T1D.
  • To explore the impact of the intervention on parental mental health.
  • To analyze communication themes within the peer support platform.

Main Methods:

  • Huddle4Parents: a 4-month digital intervention with videoconferencing (Zoom) and 24/7 texting.
  • Recruited 18 parents; 15 completed the intervention (83% retention).
  • Assessed feasibility, acceptability, satisfaction, and analyzed text message content.

Main Results:

  • High recruitment and retention rates (83%) indicate feasibility.
  • Parents reported high satisfaction and willingness to recommend the program.
  • Key themes included technology, emotional support, school management, and strategy exchange.
  • No significant changes in psychosocial outcomes were observed.

Conclusions:

  • The Huddle4Parents intervention is a feasible and acceptable digital peer support model for T1D caregivers.
  • Synchronous and asynchronous digital support effectively engages parents.
  • The intervention demonstrates potential for supporting families managing T1D.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
155